Physician profile
John Manuel Chaves
NPI 1134264518
$3,588.75
in general payments reported to CMS, 2019-2025
8 companies · $410 in 2025
The $410 reported for 2025 was more than what 88% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $154 · 2020: $140 · 2021: $395 · 2022: $1,119 · 2023: $986 · 2024: $385 · 2025: $410.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,000 · Gift: $424 · Entertainment: $183 · Education: $174.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,000.41 |
| Gift | $423.95 |
| Entertainment | $182.53 |
| Education | $174.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ultradent Products INC | $1,421.95 | 2022-2025 | Opalescence |
| Align Technology, INC. | $1,183.36 | 2019-2025 | Invisalign |
| Keystone Dental INC. | $442.15 | 2023-2024 | |
| Nobel Biocare USA | $253.37 | 2023 | Nobelactive |
| Implant Direct Sybron International LLC | $126.65 | 2019-2021 | |
| Straumann USA LLC | $88.32 | 2023-2024 | |
| Ace Surgical Supply Co., INC. | $49.98 | 2019 | |
| Orapharma, A Division of Bausch Health US, LLC | $22.97 | 2024 | Arestin |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Chaves listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.